News Genscript Biotech Corporation

Stocks

1548

KYG3825B1059

Biotechnology & Medical Research

Market Closed - Hong Kong S.E. Other stock markets 09:08:11 17/07/2026 BST			5-day change	1st Jan Change
13.22 ^HKD	-8.76%		-4.48%	+6.44%

07-16	Genscript Associate Reports $657 Million in Carvykti Sales Under License Agreement	MT
06-15	Genscript Associate Reports Promising Phase 1 Data for LB2501 in B-Cell Lymphoma	MT

All News

Mentions Relevance

07-16	Genscript Associate Reports $657 Million in Carvykti Sales Under License Agreement	MT
06-15	Genscript Associate Reports Promising Phase 1 Data for LB2501 in B-Cell Lymphoma	MT
06-14	Genscript Biotech Corporation Reports 100% Response Rate in Early Trial of LB2501 Dual-Targeting CAR-T Therapy for Relapsed B-Cell Lymphoma	CI
06-03	Genscript Associate to Present Data for Lymphoma Drug at European Conference; Shares Surge 11%	MT
06-03	Genscript Biotech Defends Operations Amid Renewed U.S. Lawmaker Scrutiny	MT
05-12	Genscript Biotech Corporation Launches Turbocho Protein Expression Kit	CI
04-14	Genscript Biotech Associate Logs $597 Million in Q1 Sales of Carvykti	MT
04-02	Jefferies Adjusts Yeahka's Price Target to HK$15.50 From HK$23, Keeps at Buy	MT
03-16	Genscript Biotech Corp reports strong FY2025 results as integrated platform strategy and global execution drive high-quality growth	RE
03-16	GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth	PR
03-16	Genscript Biotech Corporation, 2025 Earnings Call, Mar 16, 2026
03-16	Genscript Biotech Books 2025 Loss Despite 61% Growth in Revenue	MT
03-15	Genscript Biotech Corporation Announces Company Secretary Changes, Effective March 15, 2026	CI
03-15	Genscript Biotech Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-12	GenScript Opens First European mRNA Production Site in Delft, Netherlands	CI
03-11	Genscript Biotech Forecasts 2025 Loss	MT
03-10	Genscript Biotech expects FY2025 adjusted net profit of US$207.3 million-US$241.9 million	RE
03-10	Genscript Biotech Corporation Provides Earnings Guidance for the Year Ended 31 December 2025	CI
01-22	Genscript Biotech Associate Books $555 Million in Q4 CARVYKTI Sales	MT
15/10/25	GenScript Associate Books $524 Million in Q3 CARVYKTI Sales	MT
14/10/25	Genscript Biotech Receives 480 Million Yuan Payment Under Sub-License Contract	MT
18/08/25	Genscript Biotech Corporation, H1 2025 Earnings Call, Aug 18, 2025
17/08/25	Genscript Biotech Corporation Reports Earnings Results for the Half Year Ended June 30, 2025	CI
08/08/25	GenScript Biotech Corporation Unveils New Global Identity: "Scripting Possibilities" to Power the Future of Biotechnology	CI
22/07/25	Genscript Expects to Swing to H1 Profit	MT